Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/ard-2022-222519
PubMed Identifier: 36810200
Publication URI: http://europepmc.org/abstract/MED/36810200
Type: Journal Article/Review
Volume: 82
Parent Publication: Annals of the rheumatic diseases
Issue: 5
ISSN: 0003-4967